Owen B. Wallace
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Owen B. Wallace
Monte Rosa Therapeutics, Inc. reported in an 8-K filed May 2, 2024 that Owen B. Wallace resigned as Chief Scientific Officer, effective May 17, 2024.
“On April 29, 2024, Owen Wallace, the Chief Scientific Officer of Monte Rosa Therapeutics, Inc. (the "Company"), resigned from the Company effective May 17, 2024 (the “Effective Date”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Monte Rosa Therapeutics, Inc. (GLUE)
Proxy statement
Start not stated–2024-04-26
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.